Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Heatwave
Char Dham Yatra
Gyanvapi Mosque
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / DRDO's anti-coronavirus drug: Its efficacy, price, and more queries answered
India

DRDO's anti-coronavirus drug: Its efficacy, price, and more queries answered

DRDO's anti-coronavirus drug: Its efficacy, price, and more queries answered
Written by Sagar
May 17, 2021, 12:46 pm 3 min read
DRDO's anti-coronavirus drug: Its efficacy, price, and more queries answered
DRDO's COVID-19 drug has been launched. We answer your queries.

The first batch containing 10,000 doses of the anti-coronavirus drug - 2-Deoxy-D-Glucose or 2-DG - was launched by Union Defence Minister Rajnath Singh and Health Minister Harsh Vardhan today. India's top drug regulator had cleared the medicine for emergency use earlier this month. From how effective the drug is to how much will it cost - we answer your questions.

Details
Which laboratories developed this drug?

The Drugs Controller General of India (DCGI) had approved the emergency use of the drug on May 8. The medicine has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a laboratory of the Defence Research and Development Organisation (DRDO), in collaboration with the Hyderabad-based firm Dr. Reddy's Laboratories.

Details
How does the drug work?

The 2-DG drug comes in powder form in a sachet and can be consumed orally by dissolving it in water. After the drug enters the body, it accumulates in the cells that are infected with the virus, where it stops the virus from multiplying. It is a repurposed drug as the 2-DG molecule is meant for treating tumor and cancer cells.

Information
Drug supposed to act against any variant: INMAS chief

Dr. Anil Mishra, the Director of the INMAS laboratory, had explained in an earlier interview with AIR that the way this drug functions, it is expected to act against any variant of the coronavirus.

Efficacy
How effective is it?

The results of clinical trials for the drug show that a molecule present in it helps in faster recovery of hospitalized patients and also reduces their dependence on supplemental oxygen, the government says. Reportedly, in hospital trials, it was seen that 42% patients, who were administered two sachets of the drug daily, came off oxygen support by the third day.

Trials
When were the trials conducted?

Scientists at INMAS-DRDO had started experimenting with this drug early last year. In the second round of trials, conducted on 110 patients, the drug was found to be safe for use in COVID-19 patients and showed significant improvement in their recovery process. Thereafter, phase three trials were conducted on 220 patients from last December to March 2021 at 27 coronavirus hospitals in several states.

Price
How much will it cost?

The price of the drug has not been officially announced yet. However, sources suggest that each sachet is expected to cost between Rs. 500 and 600, according to News18. In fact, Dr. Reddy's has already started producing a limited quantity of the drug for hospitals. It will not be available over the counter for the time being.

Situation
India's coronavirus crisis

The launch is significant as India has been gripped by a ferocious second wave of the coronavirus and is reporting shortages of crucial drugs. In the past 24 hours, the country registered 2,81,386 coronavirus cases, the lowest surge since April 21. 4,106 deaths were also reported in the same period. Experts say the second wave may have peaked, but a third wave is possible.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Sagar
Sagar
Twitter
Sagar covers national news for NewsBytes. He has previously worked as an editorial intern at NDTV. Over the course of his near three-year career, Sagar has gained experience in news writing, copy editing, and video production. He holds a Bachelor's degree in Journalism and Mass Communication from the University of Delhi.
Latest
India
Defence Research and Development Organisation (DRDO)
COVID-19
Related
Latest
5 surprising uses of toothpaste
5 surprising uses of toothpaste Lifestyle
2022 Benda BD300 cruiser goes official with sporty looks
2022 Benda BD300 cruiser goes official with sporty looks Auto
Kymco Krider 400 arrives in global markets with sporty design
Kymco Krider 400 arrives in global markets with sporty design Auto
Your guide to traveling to Spiti Valley
Your guide to traveling to Spiti Valley Lifestyle
Fourth-generation Hyundai TUCSON breaks cover in India; launch in late-2022
Fourth-generation Hyundai TUCSON breaks cover in India; launch in late-2022 Auto
India
Pakistan commits to fighting terrorism, seeks 'balanced ties' with world
Pakistan commits to fighting terrorism, seeks 'balanced ties' with world World
10,000 people stuck as Rishikesh-Yamunotri Highway safety wall collapses
10,000 people stuck as Rishikesh-Yamunotri Highway safety wall collapses India
COVID-19: India reports 2,364 fresh cases, 10 more deaths
COVID-19: India reports 2,364 fresh cases, 10 more deaths India
Centre eases ban on wheat export: Here are more details
Centre eases ban on wheat export: Here are more details Business
Global wheat prices surge by 6% after India's export ban
Global wheat prices surge by 6% after India's export ban Business
More News
Defence Research and Development Organisation (DRDO)
Indian Air Force, Navy partner with DRDO for chaff technology
Indian Air Force, Navy partner with DRDO for chaff technology India
DRDO successfully test-fires medium-range surface-to-air missile, destroys target
DRDO successfully test-fires medium-range surface-to-air missile, destroys target India
India flight tests new generation surface-to-air Akash missile
India flight tests new generation surface-to-air Akash missile India
DRDO's anti-coronavirus drug cleared for emergency use by DCGI
DRDO's anti-coronavirus drug cleared for emergency use by DCGI India
DRDO to set up 500 oxygen plants within three months
DRDO to set up 500 oxygen plants within three months India
More News
COVID-19
Beijing: 13,000 COVID-19 negative people forced into quarantine
Beijing: 13,000 COVID-19 negative people forced into quarantine World
COVID-19: India reports 2,323 fresh cases, 25 more deaths
COVID-19: India reports 2,323 fresh cases, 25 more deaths India
COVID-19: India reports 1,829 new cases, 33 more fatalities
COVID-19: India reports 1,829 new cases, 33 more fatalities India
COVID-19: India reports 1,569 new cases, 19 more deaths
COVID-19: India reports 1,569 new cases, 19 more deaths India
COVID-19: India logs 2,202 new cases; 27 more deaths
COVID-19: India logs 2,202 new cases; 27 more deaths India
More News
Related
India may approve anti-COVID-19 drug molnupiravir soon: Report
India may approve anti-COVID-19 drug molnupiravir soon: Report India
Coronavirus: India reports 18K+ new cases, lowest in 7 months
Coronavirus: India reports 18K+ new cases, lowest in 7 months India
DRDO nod for Mankind Pharma to manufacture COVID-19 drug 2-DG
DRDO nod for Mankind Pharma to manufacture COVID-19 drug 2-DG India
COVID-19 drug 2-DG launched: All you need to know
COVID-19 drug 2-DG launched: All you need to know India
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022